The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Apolipoprotein E isoforms and lipoprotein metabolism
Abstract
Apolipoprotein (apo) E is a 299‐residue protein which functions as a key regulator of plasma lipid levels. Human apoE exists as three common isoforms and the parent form, apoE3, operates optimally in promoting clearance of triglyceride (TG)‐rich lipoproteins and is associated with normal plasma lipid levels. This result occurs because apoE3 possesses both the requisite lipid‐binding ability and affinity for the low density lipoprotein receptor (LDLR) to mediate appropriate lipolytic processing and endocytosis of TG‐rich lipoprotein remnant particles. ApoE2 which differs from apoE3 by the single amino acid substitution Arg158Cys located near the LDLR recognition site exhibits impaired binding to the receptor and an inability to promote clearance of TG‐rich lipoprotein remnant particles; this isoform is associated with Type‐III hyperlipoproteinemia. ApoE4 which differs from apoE3 by the single amino acid substitution Cys112Arg is also associated with dyslipidemia although binding of this isoform to the LDLR is unaffected. The amino acid substitution affects the organization and stability of both the N‐terminal helix bundle domain and separately folded C‐terminal domain so that apoE4 has enhanced lipid binding ability. As a consequence, apoE4 binds better than apoE3 to the surface of very low density lipoprotein (VLDL) particles and impairs their lipolytic processing in the circulation so that apoE4 is associated with a more pro‐atherogenic lipoprotein‐cholesterol distribution (higher VLDL‐cholesterol/high density lipoprotein‐cholesterol ratio). This review summarizes current understanding of the structural differences between apoE2, apoE3, and apoE4, and the molecular mechanisms responsible for the alterations in lipoprotein metabolism resulting from this polymorphism of apoE. Detailed knowledge of how expression of structurally distinct apoE variants modifies lipoprotein metabolism provides a basis for developing ways to manipulate the functionality of apoE in vivo. © 2014 IUBMB Life, 66(9):616–623, 2014
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is attributed to the fact that the cysteine change at position 158 in APOE2, near the LDLR binding region, hinders APOE2 binding to the LDLR [30, 40].”
In the citing paper
“As a result, apoE4 binds better and is more abundant on the surface of VLDL and chylomicron particles than apoE3 or apoE2 19).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [19]
Citations
Cites
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Segrest, J., Jones, M., Loof, H. D., Brouillette, C. G., Venkatachalapathi, Y. V., & Anantharamaiah, G. M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41536-6 · Cited by 868
Apolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830
Mahley, R. W., & Ji, Z.-S. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33334-4 · Cited by 693
Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34954-8 · Cited by 673
Apolipoprotein E structure: insights into function
Hatters, D. M., Peters-Libeu, C. A., & Weisgraber, K. H. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.06.008 · Cited by 583 · cited 1×
“The latter interaction occurs in quasi-spherical apoE/dipalmitoyl phosphatidylcholine particles where the two apoE molecules adopt a horseshoe shape (7,26).”
BackgroundApolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800069-jlr200 · Cited by 580
Mahley, R. W., Huang, Y., & Rall, S. C. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32417-2 · Cited by 447
Apo E structure determines VLDL clearance and atherosclerosis risk in mice
Knouff, C., Hinsdale, M. E., Mezdour, H., Altenburg, M. K., Watanabe, M., Quarfordt, S. H., Sullivan, P. M., & Maeda, N. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6172 · Cited by 324
Dong, L. M., Wilson, C., Wardell, M. R., Simmons, T., Mahley, R. W., Weisgraber, K. H., & Agard, D. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31797-0 · Cited by 320
Cited by
Sorted by citations
Items 201–300 of 328
“Association of APOE gene polymorphisms with primary open angle glaucoma in Brazilian patients”
Occhiutto, M. L., de Melo, M. B., de Vasconcellos, J. P. C., Rodrigues, T. A. R., Bajano, F. F., Costa, F. F., & Costa, V. P. (2020) · Ophthalmic Genetics · doi:10.1080/13816810.2020.1849314 · Cited by 6
Reassessing Diabetes and APOE Genotype as Potential Interacting Risk Factors for Alzheimer’s Disease
Ravipati, K., Chen, Y., & Manns, J. R. (2022) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175211070912 · Cited by 6
Thomford, N. E., Anyanful, A., Ateko, R. O., Blackhurst, D., Biney, R. P., Boadi, D., Nyarko, S. B., Ekor, M., & Kyei, G. B. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284697 · Cited by 5
Park, S., Sim, Y. E., Kang, M., Kim, D. Y., Kang, I., Lim, S. S., & Kang, Y. (2023) · Nutrition Research and Practice · doi:10.4162/nrp.2023.17.6.1099 · Cited by 5
Apolipoprotein E3 and E4 isoforms exhibit differing effects in countering endotoxins
Puthia, M., Marzinek, J. K., Veselá, K., Larsson, A., Schmidtchen, A., Bond, P. J., & Petrlová, J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108236 · Cited by 5
Tian, Q., & Zhao, X. (2015) · Gut · doi:10.1136/gutjnl-2015-310460 · Cited by 5
Kovtun, O. P., & Ustiuzhanina, M. A. (2018) · Вопросы современной педиатрии · doi:10.15690/vsp.v17i4.1924 · Cited by 5
Association of ApoE haplotype with clinical evidence of pituitary adenoma
Sidaraitė, A., Vilkevičiūtė, A., Glebauskienė, B., Kriaučiūnienė, L., Žaliūnienė, D., & Liutkevičienė, R. (2019) · Gene · doi:10.1016/j.gene.2019.04.090 · Cited by 5
Tada, H., Yamagami, K., Kojima, N., Shibayama, J., Nishikawa, T., Okada, H., Nomura, A., Usui, S., Sakata, K., Takamura, M., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.625852 · Cited by 5
Eruptive xanthomas in a patient with soft-drink diabetic ketosis and apolipoprotein E4/2
Tsuchiya, S., Sawada, S., Takeda, K., Takahashi, K. A., Nakajima, T., Kohata, M., Kurosawa, S., Satake, C., Imai, J., Kikuchi, K., et al. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0356 · Cited by 5
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820122-0.00004-2 · Cited by 6
ApoE isoform leading to hypertriglyceridemia in new onset type 1 diabetes
Keefe, C., & Lawson, S. A. (2018) · Clinical Case Reports · doi:10.1002/ccr3.1584 · Cited by 5
Lipoprotein Metabolism and Cholesterol Balance
Acuña, M., & Cohen, D. E. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch22 · Cited by 5
The impact of APOE ε4 in Alzheimer’s disease: a meta-analysis of voxel-based morphometry studiesPreprint
Bailey, M., Ilchovska, Z. G., Hosseini, A. A., & Jung, J. (2024) · medRxiv · doi:10.1101/2024.05.10.24307165 · Cited by 5
Aries, M. L., Gasvoda, H., Michelotti, M., Rodriguez-Caro, F., Gooman, A., Perez, A., & Hensley‐McBain, T. (2025) · mSphere · doi:10.1128/msphere.00429-25 · Cited by 4
Laing, K. K., Fialova, N., Wardlaw, J. M., & Montagne, A. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02018-3 · Cited by 4
Benedicto, V., Haguar, Z., Abdulhasan, A., & Narayanaswami, V. (2024) · ACS Omega · doi:10.1021/acsomega.3c09120 · Cited by 4
Unraveling APOE4's Role in Alzheimer's Disease: Pathologies and Therapeutic Strategies
Tripathi, S., Sharma, Y., & Kumar, D. (2024) · Current Protein and Peptide Science · doi:10.2174/0113892037326839241014054430 · Cited by 5
Conformational analysis of apolipoprotein E3/E4 heteromerization
Tu, K., Abhari, D., & Narayanaswami, V. (2019) · The FEBS Journal · doi:10.1111/febs.14794 · Cited by 4
Jackson, K. G., Lockyer, S., Carvalho-Wells, A. L., Williams, C. M., Minihane, A. M., & Lovegrove, J. A. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600688 · Cited by 4
Xu, J., Huang, X., Guo, Y., Ma, X., Li, P., Zhou, S., Zhang, C., Chen, R., Halm‐Lutterodt, N. V., & Yuan, L. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12855 · Cited by 4
Personalized Nutrition to Treat and Prevent Obesity and Diabetes
Panduro, A., Román, S., Milán, R. G., Torres-Reyes, L. A., & González-Aldaco, K. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160608-00272 · Cited by 4
Todorovová, V., Altschmiedová, T., Vrablík, M., & Češka, R. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.849008 · Cited by 4
Ihoeghian, N. A., Abbas, U. L., Imam, I. A., & Shao, Q. (2025) · Physical Chemistry Chemical Physics · doi:10.1039/d5cp03829d · Cited by 3
Insights into the C-terminal domain of apolipoprotein E from chimera studies with apolipophorin III
Horn, J. V. C., Kakutani, L. M., Narayanaswami, V., & Weers, P. M. M. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04497-y · Cited by 3
Klen, J., Goričar, K., & Dolžan, V. (2023) · Journal of Medical Biochemistry · doi:10.5937/jomb0-43154 · Cited by 4
Darabi, N., Mashayekhy, M., Boroujeni, P. B., Mohtasebi, P., Talab, Z. R., & Zamanian, M. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15537 · Cited by 3
Human APOE ɛ3 and APOE ɛ4 Alleles Have Differential Effects on Mouse Olfactory Epithelium
Khan, N., Alimova, Y. V., Clark, S. J., Vekaria, H. J., Walsh, A. E., Williams, H. C., Hawk, G. S., Sullivan, P. G., Johnson, L. A., & McClintock, T. S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215152 · Cited by 5
Variations in high density cholesterol levels based on apolipoprotein E variant and exercise type
Chang, C.-M., Nfor, O. N., Ho, C., Chen, P.-H., & Liaw, Y. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1136483 · Cited by 3
Apolipoprotein E isoforms differentially affect LCAT-dependent cholesterol esterification
Vitali, C., Pavanello, C., Turri, M., Lund‐Katz, S., Phillips, M. C., Catapano, A. L., Baragetti, A., Norata, G. D., Veglia, F., & Calabresi, L. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117266 · Cited by 3
Self-citationMirheydari, M., Putta, P., Mann, E. K., & Kooijman, E. E. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c00271 · Cited by 3
Mining the potential therapeutic targets for coronary artery disease by bioinformatics analysis
Wang, W., Xu, Z., Zhu, X., & Chang, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9551 · Cited by 3
Hazarika, L., Sen, S., Zawar, A., & Doshi, J. (2021) · Journal of Drug Design and Medicinal Chemistry · doi:10.11648/j.jddmc.20210702.11 · Cited by 3
Apolipoprotein E interacts with amyloid-β oligomers via positively cooperative multivalent bindingPreprint
Ghosh, S., Sil, T. B., Dolai, S., & Garai, K. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/473892 · Cited by 3
[A short discharge letter with a copy to the patient--satisfactory for patients and practitioners].
Nielsen, F. T., Rosholm, J.-U., Søndergaard, J., Gohr, T., & Tougaard, L. (1994) · PubMed · Cited by 3
O’Niel, A., Parkins, C. J., Pederson, A., Saltonstall, E., Bunnell, E., Aggarwal, R., Sandholm, P., Kessler, K., Harrison, H. F., Smith, J. R., et al. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1600119 · Cited by 2
The APOE Gene Cluster in Normal Aging
Florczak‐Wyspianska, J., Hurła, M., Pikor, D., Poszwa, J., Korczowska-Łącka, I., Szymanowicz, O., Pluto-Prądzyńska, A., Goutor, U., Wiszniewska, M., Kozubski, W. P., et al. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin36401 · Cited by 3
Tou, H. I., Rosenes, Z., Khandokar, Y. B., Zlatic, C. O., Metcalfe, R. D., Mok, Y.-F., Morton, C. J., Gooley, P. R., & Griffin, M. D. W. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169394 · Cited by 2
Jin, T., Yang, H., Liu, F., Lin, S., Hu, J., Wang, J., & Gou, Y. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70224 · Cited by 2
Picklo, M. J., RUST, B. M., Yeater, K. M., & Raatz, S. K. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.06.005 · Cited by 2
Bekenova, N., Aitkaliyev, A., Vochshenkova, T. A., Kassiyeva, B., & Benberin, V. V. (2024) · Diagnostics · doi:10.3390/diagnostics14171978 · Cited by 2
Effects of APOE isoforms in diabetic nephropathy patients of South India
Basavaraju, P., Moorthi, P. V., Meyyazhagan, A., Devaraj, I., Babu, K., Panza, E., & Orlacchio, A. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02374-2 · Cited by 2
Radiolabeling lipoproteins to study and manage disease
Pérez‐Medina, C., Fisher, E. A. A., Fayad, Z. A., Mulder, W. J. M., & Teunissen, A. J. P. (2025) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-025-07281-4 · Cited by 2
King, R. I., & Brennan, S. O. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.03.021 · Cited by 2
Pediatric dyslipidemias: lipoprotein metabolism disorders in children
Ballout, R. A., & Remaley, A. T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817962-8.00002-0 · Cited by 3
Qu, F., Yang, X., Yang, J., Zhou, Q., Yang, X., Chen, M., Xiong, Y., & Hu, Y. (2022) · Psychogeriatrics · doi:10.1111/psyg.12808 · Cited by 2
Isolation of recombinant apolipoprotein E4 N-terminal domain by foam fractionation
Lethcoe, K., Fox, C. A., Hafiane, A., Kiss, R. S., & Ryan, R. O. (2023) · Protein Expression and Purification · doi:10.1016/j.pep.2023.106319 · Cited by 2
Пересецкая, О. В., Kozlova, L. V., Larionova, V. I., & Smolensk, R. F. (2024) · Doctor Ru · doi:10.31550/1727-2378-2024-23-3-67-72 · Cited by 2
Protein corona critically affects the bio-behaviors of SARS-CoV-2Preprint
Yin, Y.-W., Sheng, Y.-J., Wang, M., Ni, S., Ding, H.-M., & Ma, Y. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2102.05440 · Cited by 4
Apolipoprotein E deficiency enhances the anti-tumor immunity via repressing T cell exhaustion
Zhao, B., Wang, W., Chen, Z., & Jin, S. (2021) · All Life · doi:10.1080/26895293.2021.2001382 · Cited by 1
Shamsudin, A. F., Sulong, S., Ahmad, I., & Bakar, N. S. (2024) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-024-00523-4 · Cited by 1
Apolipoprotein-ε4 (APOE) Gene Is a Risk Factor for Human Coronary Artery Disease
Hazarika, L., & Sen, S. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_61-1 · Cited by 1
Sambhariya, W. S., Rickman, C. B., D'Amore, P. A., Corradetti, G., Hageman, G. S., Howell, G. R., Marola, O. J., Phatnani, H. P., Philp, N. J., Sinha, D., et al. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101449 · Cited by 1
The Design Strategies and Applications of Engineered Nanoparticles for Traumatic Brain Injury
Xiang, C., Zhu, Y., Gao, X., Guo, F., He, X., Luo, W., Liu, W., & Gu, R. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s591179 · Cited by 1
APOE, Inflammation, and T Cells in Translational Disease Models and Clinical Medicine
Adlimoghaddam, A., Cervantes, D., & Wheeler, C. J. (2026) · Springer eBooks · doi:10.1007/978-3-031-96089-5_35 · Cited by 1
Systemic immunosuppression limits NK cell therapy efficacy in pancreatic cancer
He, C., Wang, D., Hu, T., Gonzalez, D., Thakur, R., Matysniak, D. P., King, R. J., Kollala, S. S., Markov, S. D., Fujii, Y., et al. (2026) · Molecular Cancer · doi:10.1186/s12943-025-02340-8 · Cited by 1
Gorshkova, I. N., & Atkinson, D. (2017) · PubMed · Cited by 1
ApoE: A Risk Factor for Dementia
Jeelani, H., Nabi, J., Akhter, Y., Tabasum, N., Afroze, D., Pottoo, F. H., & Ali, F. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_1 · Cited by 2
Lusiki, Z., Blom, D. J., Soko, N. D., Malema, S., Jones, E. S. W., Rayner, B. L., Blackburn, J. M., Sinxadi, P., Dandara, M. T. L., & Dandara, C. (2023) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2023.0122 · Cited by 1
Nawabi, A. Q., Yang, M., Cai, X., Gou, W., Hou, J., Nizami, V., & Dai, Q. (2019) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2019.911074 · Cited by 1
Purification and Analysis of Circulating Lipid Particles
Roper, B. W. R., Alsayejh, B., Al-Aufi, A., Cuthbert, G. A., Lacey, K., Homer‐Vanniasinkam, S., Harrison, M. A., Tomlinson, D. C., Ajjan, R., & Ponnambalam, S. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1924-7_12 · Cited by 1
Bernardes, C. P., dos Santos, N. A. G., Costa, T. R., Menaldo, D. L., Sisti, F., Amstalden, M. K., Ribeiro, D. L., Antunes, L. M. G., Sampaio, S. V., & dos Santos, A. C. (2023) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-023-10517-2 · Cited by 1
Chakraborty, A., Changlin, Y., Silver, A., Feier, D., Tian, G., Pittu, A., Roemeling, C. A. V., Thomas, N. J., Andrews, M., Conforti, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.07.658345 · Cited by 1
Lipoproteins and Health Outcomes: Cognitive and Physical Function in Older Adults
Chanti‐Ketterl, M. (2015) · Digital Commons - University of South Florida (University of South Florida)
Evolutionary Imprints on Cardiovascular Physiology and Pathophysiology
Danziger, R. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-29716-3_11
Gumina, R. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.10920-1
Pharmacogenetics and Pharmacogenomics in Cardiovascular Medicine and Surgery
Turner, R. M., & Pirmohamed, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-66114-8_5
Inhibitory Effects of Goishi Tea on Atherosclerosis in Apolipoprotein E Deficient Mice
Ishida, N., Ishida, T., Morisawa, S., Iizuka, M., Yagi, Y., Jobu, K., Morita, Y., Oishi, M., Moriyama, H., Shimamura, T., et al. (2020) · Food Science and Technology Research · doi:10.3136/fstr.26.509
Apolipoproteina E şi progresia nefropatiei la pacienţii diabetici
Facultatea de Medicină Universitatea de Vest „Vasile Goldiş“, A., Moldovan, S. D., Popețiu, R. O., Facultatea de Medicină Universitatea de Vest „Vasile Goldiş“, A., Amza, O. L., Facultatea de Medicină Universitatea de Vest „Vasile Goldiş“, A., Pușchiță, M., & Facultatea de Medicină Universitatea de Vest „Vasile Goldiş“, A. (2019) · Romanian Medical Journal · doi:10.37897/rmj.2019.3.9
The interactive impact of omega-3 fatty acids, APOE genotype and sex hormones on cognition
Pontifex, M. G. (2020) · UEA Digital Repository (University of East Anglia)
Polymorphisms of apolipoprotein E in the Afro-descendant population of Buenaventura, Colombia
Perdomo, V. A., Ortega, D. C., & Barreto, G. (2020) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2020.10.010
Lipoprotein Subfractions in Clinical Practice
Meeusen, J. W. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_27
Rangel, B., & Milena, A. (2021)
Pizzorno, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00203-x
Covarrubias, R., Major, A. S., & Gumina, R. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.10920-2
Features of Lipid Metabolism in HCV Infection
Васильевна, В. Г. (2021) · Клиническая инфектология и паразитология · doi:10.34883/pi.2020.9.4.028
Shamsudin, A. F., & Bakar, N. S. (2022) · doi:10.22541/au.166721405.51189611/v1
Allele Frequencies of Apolipoprotein E in a South Western Nigerian population on HAART
BAMIDELE, O. T., Olayanju, O. A., Emuze, M. E., Akande, J. O., Nduka, N. S., Eseile, B., Olasehinde, O. E., & Kuti, M. A. (2022) · Babcock University Medical Journal · doi:10.38029/babcockunivmedj.v5i2.160
Oler, J. R. L., Hoogerheide, E. S. S., Tiago, A. V., & Pinto, J. M. A. (2023) · doi:10.22533/at.ed.4552309053
Batista, J. E. D. S., da Silva, V. S., & Klamt, F. (2023) · doi:10.22533/at.ed.4552309054
Anacardium occidentale L. (ANACARDIACEAE): ANTIBACTERIAL AND ANTIBIOTIC POTENTIATING ACTIVITY
Ulisses, V. R. D. A., Costa, A. R., Coutinho, H. D. M., Pereira, R. L. S., dos Santos, C. A. L., Teles, B. R. D. S., dos Santos, L. B., Silva, L. V., Almeida‐Bezerra, J. W., de Oliveira, M. G., et al. (2023) · doi:10.22533/at.ed.4552309056
de Castro, V. F., Cabral, L. M., & Hoffmann, L. (2023) · doi:10.22533/at.ed.4552309051
la Fuente, A. O. R., Heredia-Rojas, J. A., Rebollar-Téllez, E. A., Noguera-Díaz, P. A., Martínez, P. C. C., & Heredia-Rodríguez, O. (2023) · doi:10.22533/at.ed.4552309055
Principais temas da pesquisa em Ciências Biológicas 2
da Silva, E. (2023) · doi:10.22533/at.ed.455230905 · Cited by 1
TRANSPLANTE MITOCONDRIAL: ASPECTOS TECNOLÓGICOS E APLICAÇÕES CLÍNICAS DA MITOTERAPIA
Albrecht, P. A. C., Galina, A., & Klamt, F. (2023) · doi:10.22533/at.ed.4552309052
Dayspring, T. D., & Toth, P. P. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_4
Association of APOE polymorphisms with serological lipid and inflammatory markersPreprint
Krishnamurthy, H. K., Rajavelu, I., Reddy, S., Pereira, M., Jayaraman, V., Krishna, K., Song, Q., Wang, T., Bei, K., & Rajasekaran, J. J. (2023) · Research Square · doi:10.21203/rs.3.rs-3159674/v1
Saldan, Y. (2023) · ScienceRise Medical Science · doi:10.15587/2519-4798.2023.282363
Salman, M. N., Aljanabi, A. A., & Al-Kashwan, T. A. J. (2023) · Research Square · doi:10.21203/rs.3.rs-3277707/v1
Pathophysiology of degenerative cervical myelopathy
Hong, J., Araujo, G. L., Janevski, J., Li, R., Sharma, M., Vidal, P. M., Sadat, S., & Fehlings, M. G. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95334-4.00018-8
Wolf, E. J., Miller, M. W., Zhang, R., Sherva, R., Harrington, K. M., Fonda, J. R., Daskalakis, N. P., Gaziano, J. M., & Logue, M. W. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00225-1 · Cited by 1
Thu, N. H. H., Linh, N. T., Thương, M. T. H., Dương, N. T., & Hà, N. H. (2024) · Vietnam Journal of Biotechnology · doi:10.15625/1811-4989/19504
Acute Hemorrhagic Stroke and Neurocritical Care
Murali, T. (2024) · Springer eBooks · doi:10.1007/978-981-99-8059-8_52
Narayanaswami, V., Reddick, I., Celis, G., Pal, S., Nguyen, J., Deepa, S., & Garai, K. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5158139
Reddick, I., Celis, G., Pal, S., Nguyen, J., Saraswathi, D., Garai, K., & Narayanaswami, V. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110421
Correas, Á. G., Stromsnes, K., Lupu, R. I., & González, G. O. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_29-1 · Cited by 1
ApoE, Atherosclerosis, and Hypercholesterolemia
Shi, W. (2025) · Springer eBooks · doi:10.1007/978-3-031-52641-1_26-1
Genetic Polymorphisms of Apolipoprotein E and Their Impact on Ischemic Stroke Severity and Recovery
Yuan, H., Li, P., & Li, B. (2025) · Neurology and Clinical Neuroscience · doi:10.1111/ncn3.70025
Metadata
- Authors
- Phillips, M. C.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Phillips, Michael C.
- ORCID
- Phillips, Michael C.
- Venue
- IUBMB Life
- Publisher
- Wiley
- Published
- 2014-09
- Volume
- 66
- Issue
- 9
- Pages
- 616-623
- ISSN
- 1521-6543 (ISSN-L)
- 1521-6551
- OpenAlex
- W1841798962
- Cited by
- 328
- References
- 59
- Citations by year
- 2026: 20 · 2025: 25 · 2024: 41 · 2023: 35 · 2022: 36 · 2021: 38 · 2020: 27 · 2019: 27 · 2018: 24 · 2017: 23 · 2016: 22 · 2015: 8
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- IUBMB Life (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- apolipoprotein E, apolipoprotein E isoforms, apolipoprotein E2, apolipoprotein E3, APOE ε4, lipoprotein metabolism, LDL receptor binding, type III hyperlipoproteinemia, dyslipidemia, VLDL cholesterol, protein structure, lipid binding, genetic polymorphism
- MeSH terms
- Apolipoproteins E, Humans, Lipoproteins, Models, Molecular, Protein Binding, Amino Acid Substitution, Protein Isoforms, Lipid Metabolism Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review